PRODUCTS
Liren Medical Technology
Alpelisib?(Synonyms: BYL-719)
Catalog Number: HY-15244
Purity: 99.90%
Data Sheet SDS
Product Usage Guide
Alpelisib (BYL-719) is a potent, selective, orally active PI3Kα inhibitor. Alpelisib (BYL-719) is targeted for PIK3CA mutant cancers. Alpelisib (BYL-719) inhibited p110α, p110γ, p110δ, and p110β with IC50 of 5 nM, 250 nM, 290 nM, and 1200 nM, respectively. With antitumor activity. All MCE products are used for scientific research only, we do not provide products and services for any personal use
Structural formula:
HOME | ABOUT US | PRODUCTS | RESEARCH | JOBS | CONTACT US | 中文版
Copyright(C)2022, Changzhou Liren Medical Technology Co., Ltd. All Rights Reserved. Supported by ChinaChemNet ChemNet Toocle Copyright Notice 備案序號(hào):蘇ICP備16022678號(hào)